Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis (Q28078717)

Shuo Yang

2

1 reference

Rong Li

3

1 reference

Ping Liu

4

1 reference

Jie Qiao

5

1 reference

Yanwu Zhang

6

1 reference

Reproductive Biology and Endocrinology

language of work or name

1 reference

18 October 2016

7 references

13 March 2019

24 March 2019

3 April 2019

20 June 2019

29 May 2020

18 July 2020

7 references

13 March 2019

24 March 2019

3 April 2019

20 June 2019

29 May 2020

18 July 2020

14

1 reference

page(s)

67

1 reference

issue

1

1 reference

Creative Commons Attribution 4.0 International

copyright license

5 references

13 March 2019

24 March 2019

3 April 2019

20 June 2019

on focus list of Wikimedia project

18 July 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s12958-016-0203-8

0 references

cites work

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Phenotype and metabolic disorders in polycystic ovary syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

The metabolic syndrome in young Korean women with polycystic ovary syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison

29 September 2017

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12958-016-0203-8

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5069996

Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome

27 November 2018

1 reference

12 December 2020

The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids

1 reference

12 December 2020

Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria

1 reference

12 December 2020

Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria

1 reference

12 December 2020

The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism

1 reference

12 December 2020

10.1186/S12958-016-0203-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2935264

1045960383

0 references

Fatcat ID

release_d2rsxgwjhjbu5fjuq2n642hc4y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d2rsxgwjhjbu5fjuq2n642hc4y

24 November 2022

mapped directly with Wikidata item

2935264

1 reference

1 reference

1 reference